<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02503475</url>
  </required_header>
  <id_info>
    <org_study_id>22436</org_study_id>
    <nct_id>NCT02503475</nct_id>
  </id_info>
  <brief_title>Stanford Center for Back Pain</brief_title>
  <official_title>Stanford Center for Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the Stanford Center for Back Pain is to investigate and characterize the&#xD;
      mechanisms of four treatments for chronic low back pain. These interventions (research&#xD;
      treatment) include real-time fMRI neurofeedback, mindfulness based stress reduction,&#xD;
      cognitive behavioral therapy, and acupuncture treatment. The investigators plan to&#xD;
      characterize both mechanisms of treatment effects and efficacy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Stanford Center for Back Pain establishes a collaborative, multidisciplinary research&#xD;
      program to investigate CAM interventions for the treatment of chronic low back pain (CLBP).&#xD;
      The investigators' overall goal is to characterize the shared and distinct mechanisms of four&#xD;
      CAM interventions and translate the investigators' findings to tailored and effective&#xD;
      treatments for CLBP. CLBP is a highly prevalent and difficult-to-treat condition for which&#xD;
      many patients seek CAM therapies. Basic science has revealed that abnormalities in central&#xD;
      pain modulatory and emotion regulatory systems play a crucial role in CLBP. What is not clear&#xD;
      is how CAM therapies alter the functioning of the brain systems involved in chronic pain. The&#xD;
      Stanford Center for Back Pain aims to fill this gap by conducting 3 projects, each aiming at&#xD;
      elucidating mechanisms underlying different CAM therapies for CLBP.&#xD;
&#xD;
      Project 1 will focus on a promising novel alternative therapy for CLBP real-time fMRI&#xD;
      neurofeedback which trains patients to control specific neural processes that lead to&#xD;
      improvements in pain. Project 2 will characterize the pain modulatory and emotion regulatory&#xD;
      effects of mindfulness based stress reduction and cognitive behavioral therapy for CLBP.&#xD;
      Project 3 will characterize psychophysical and neuroimaging based neural mechanisms&#xD;
      underlying verum and placebo acupuncture.&#xD;
&#xD;
      The Stanford Center for Back Pain will provide optimal collaboration and synergy within a&#xD;
      multidisciplinary framework to identify mechanisms of CAM therapies for CLBP so that they can&#xD;
      eventually translate them into enhance clinical care of CLBP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in pain severity</measure>
    <time_frame>Up to 12 months post-treatment</time_frame>
    <description>Visual Analogue Scale from 0 to 100, where 0=no pain and 100=worst pain imaginable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in pain symptom severity and well being</measure>
    <time_frame>Up to 12 months post-treatment</time_frame>
    <description>Responses to NIH PROMIS measures such as Pain Interference, Pain Behavior, Physical Function, Fatigue, Sleep Disturbance</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Project 1- Real-Time fMRI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This arm investigates Real-Time fMRI within 4 groups:&#xD;
Attention Regulation (AR) Group- Experimental Cognitive Regulation (CR) Group- Experimental Sham Group- Sham Comparator Free Strategy Group- Active Comparator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Project 2 - CBT/MBSR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm investigates 2 experimental groups:&#xD;
Cognitive Behavioral Therapy (CBT) Mindfulness Based Stress Reduction (MBSR)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Project 3- Acupuncture</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This arm investigates Acupuncture within 2 groups:&#xD;
Verum- Experimental Sham- Sham comparator</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Real-Time fMRI</intervention_name>
    <description>Real-Time fMRI: AR, CR, Sham, and Free Strategy groups will be compared to determine the following:&#xD;
(1) whether a cognitive strategy improves rtfMRI neurofeedback to modulate brain activity and pain; (2) which strategy is most effective at individual and group levels at modulating brain activity and pain; and (3) whether the investigators can predict individual ability to modulate brain activity or pain using a particular strategy and applying mixed effects modeling of treatment efficacy using baseline measurements.</description>
    <arm_group_label>Project 1- Real-Time fMRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CBT or MBSR</intervention_name>
    <description>CBT/MBSR: The study will investigate whether CBT versus MBSR differentially enhance behavioral and neural indices of the ability to implement cognitive regulation (CR) and attention regulation (AR) during evoked pain in the lower back in participants with chronic low back pain. An additional wait list control (WL) group will be used to determine the effects of time on pain symptom severity and well-being.</description>
    <arm_group_label>Project 2 - CBT/MBSR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acupuncture</intervention_name>
    <description>Acupuncture: The investigators will compare the efficacy and mechanisms of verum and sham electroacupuncture.</description>
    <arm_group_label>Project 3- Acupuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  English Fluency&#xD;
&#xD;
          -  Chronic Low Back Pain as defined by NIH task-force or Healthy Controls&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  MRI contraindications&#xD;
&#xD;
          -  Pregnant or planning to become pregnant&#xD;
&#xD;
          -  Medical conditions that would interfere with study procedures, at the discretion of&#xD;
             the study team&#xD;
&#xD;
          -  Neurologic disorder, history of seizures, stroke, or brain abnormalities, which would&#xD;
             interfere with brain integrity, at the discretion of the study team.&#xD;
&#xD;
          -  Mental health conditions or treatment for mental health problems that would interfere&#xD;
             with study procedures, at the discretion of the study team.&#xD;
&#xD;
          -  Other project specific criteria may apply.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sean Mackey, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Gross, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rachel Manber, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sean Mackey, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Corinne Jung, PhD</last_name>
    <phone>650-724-0522</phone>
    <email>cejung@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corinne Jung, PhD</last_name>
      <phone>650-724-0522</phone>
      <email>cejung@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 15, 2015</study_first_submitted>
  <study_first_submitted_qc>July 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 21, 2015</study_first_posted>
  <last_update_submitted>September 16, 2021</last_update_submitted>
  <last_update_submitted_qc>September 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Sean Mackey</investigator_full_name>
    <investigator_title>Redlich Professor Departments of Anesthesiology, Perioperative and Pain Medicine | Neurosciences | Neurology (by courtesy), Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab (SNAPL), Stanford University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

